OncoTEX has made a significant leap in the future of cancer treatment by acquiring a gold compound platform technology, AuraTEX, that helps destroy cancer cells by using the body’s immune system. businessinsider.com.au/how-gold-compo…

OncoTEX Inc. is pleased to announce its Chem Soc Rev submission discussing how novel gold compounds can activate the immune system to destroy cancer. oncotexinc.com/2022/02/chemic…

OncoTEX is committed to transforming current cancer treatments to address urgent unmet clinical needs. #WorldCancerDay #CloseTheCareGap

OncoTEX is proud to celebrate the 65th birthday of pioneer chemist and cancer survivor, Professor Jonathan Sessler. Prof Sessler’s Texaphyrin molecules are the prime components of our TEX Core anticancer drug platform, and will someday help save lives. sciencedirect.com/science/articl…